期刊文献+

羟乙基淀粉130/0.4急性高容量血液稀释对凝血功能的影响

The influence of acute hypervolemic hemodilution with hydroxyethyl starch(130/0.4) on coagulation
下载PDF
导出
摘要 目的观察6%羟乙基淀粉130/0.4(万汶)急性高容量血液稀释对凝血功能的影响。方法择期骨科手术患者60例,ASAⅠ-Ⅱ级,年龄18-60岁,随机分为2组,每组30例,入室后于麻醉诱导前以30 ml/min的速度分别输入6%羟乙基淀粉200/0.5(贺斯)或万汶20 ml/kg。测定稀释前(t1)、稀释完成(t2)、稀释后15 min(t3)的MAP、HR、CVP。t1、t3均测定血常规及血栓弹力描记图(TEG)各指标。结果与t1比较,两组患者t2、t3的CVP和MAP均显著升高(P〈0.01);t3两组HR均升高(P〈0.05),Hb、HCT、PLT、MA均下降(P〈0.05),贺斯组TEG的K时间延长,α角减少(P〈0.05)。与贺斯组比较,万汶组t3PLT升高(P〈0.05)。结论万汶与贺斯具有相似的扩容效果,但万汶对患者凝血功能的抑制程度比贺斯小。 Objective To evaluate the effect of acute hypervolemie hemodilution ( AHHD ) with hydroxyethyl stareh(HES 130/0. 4)on blood coagulation. Methods Sixty ASA Ⅰ - Ⅱ adult patients undergoing orthopedic surgery were entered in the double-blind study. The patients were randomized to receive 20 ml/kg of either HES 200/0. 5 or HES 130/0. 4 in 30 ml/min before induction. MAP,HR and CVP were recorded before AHHD ( t1 ), at the end of AHHD ( t2 ) and 15 minutes after AHHD ( t3 ). Venous blood samples were taken at h and t3 for determination of Hb, HCT, PLT and thromboelaseograthy (TEG). Results Comparing with the value of h ,CVP and MAP were increased at t2 and t3(P 〈0. 01 ). HR was increased and Hb,HCT,PLT,MA were decreased in both groups at t3 ( P 〈 0. 05 ). At the same time, K time was prolonged and angle α was decreased in group HES 200/0. 5 ( P 〈 0. 05 ). PLT in group HES 130/0.4 was higher than in group HES 200/0. 5 at t3 ( P 〈 0. 05). Conclusion HES 130/0. 4 has same effect on blood volume expansion comparing with HES 200/ 0. 5. HES 130/0.4 compromises the coagulation function less than HES 200/0. 5.
出处 《中国实用医药》 2008年第24期20-21,共2页 China Practical Medicine
关键词 羟乙基淀粉 血液稀释 血栓弹力描记术 血液凝固 Hydroxyethyl starch Blood coagulation Hemodilution Thromboelaseograthy
  • 相关文献

参考文献7

  • 1[1]Thyes C,Madjdpour C,FrascaroloO P,et 81.Effect of High-and lowmolecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs.Anesthesiology,2006,105:1228-1237.
  • 2[2]LIU Huai-qiong,LIU Su.Review and prospect of haemodilution.Chin J Anesthesiol,2006,26:197-198.
  • 3[3]Welsby IJ,Jiao K,Ortel TL,et al.The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery.J Cardiothorac Vasc Anesth,2006,20:531-535.
  • 4[4]Mousa SA,Khurana S,Forsythe MS.Comparative in vitro efficacy of different platelet glycoprotein Ⅱ b/Ⅲ a antagonists on platelet-mediated clot strength induced by tissue factor with use of thrombelastography:differentiation among glycoprotein Ⅱ b/Ⅲ a antagonists.Arterioscler Thromb Vasc Biol,2000,20(4):1162-1167.
  • 5[5]Franz A,Braunlich P,Foringer C,et al.The effects of hydroxyethyl starches of varying molecular weight on platelet function.Anesth Analg,2001,92(6):1402-1407.
  • 6[6]Strauss RG.All formulations of hydroxyethyl starch are not the same.Transfusion,2007,47:1329 -1330.
  • 7[7]Ickx BE,Bepperling F,Melot C,et al.Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution.Br J Anacsth,2003,91 (2):196-202.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部